![SBRT in Prostate Cancer at ESTRO24](https://oncodaily.com/pub/uploads/2024/08/estro24.png)
Photo from ESTRO/LinkedIn
Aug 26, 2024, 06:20
SBRT in Prostate Cancer at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Five-year outcomes from the hypo-FLAME trial, acute toxicity results from the PACE-C trial, and key findings from the STORM trial were revealed at ESTRO24. Learn how SBRT is advancing treatment and improving outcomes in prostate cancer.”
Read further.
Source: ESTRO/LinkedIn
More posts featuring ESTRO24 on oncodaily.com
Aug 26, 2024, 06:10